-
2
-
-
0027536554
-
Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system
-
Brunner HR, Nussberger J, Waeber B. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system. J Hypertens Suppl 1993;11:S53-58.
-
(1993)
J Hypertens Suppl
, vol.11
-
-
Brunner, H.R.1
Nussberger, J.2
Waeber, B.3
-
3
-
-
0027456644
-
Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure
-
Rush JE, Rajfer SI. Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure. J Hypertens Suppl 1993;11:S69-71.
-
(1993)
J Hypertens Suppl
, vol.11
-
-
Rush, J.E.1
Rajfer, S.I.2
-
4
-
-
0027324780
-
EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells
-
Sachinidis A, Ko Y, Weisser P, Meyer zu Brickwedde MK, Dusing R, Christian R, Wieczorek AJ, Vetter H. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells. J Hypertens 1993;11:155-162.
-
(1993)
J Hypertens
, vol.11
, pp. 155-162
-
-
Sachinidis, A.1
Ko, Y.2
Weisser, P.3
Meyer Zu Brickwedde, M.K.4
Dusing, R.5
Christian, R.6
Wieczorek, A.J.7
Vetter, H.8
-
5
-
-
0029588499
-
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
-
Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther 1995;58:641-649.
-
(1995)
Clin Pharmacol Ther
, vol.58
, pp. 641-649
-
-
Lo, M.W.1
Goldberg, M.R.2
McCrea, J.B.3
Lu, H.4
Furtek, C.I.5
Bjornsson, T.D.6
-
6
-
-
0030724427
-
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers
-
DOI 10.1016/S0009-9236(97)90120-X
-
Kazierad DJ, Martin DE, Blum RA, Tenero DM, Ilson B, Boike SC, Etheredge R, Jorkasky DK. Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers. Clin Pharmacol Ther 1997;62:417-425. (Pubitemid 27475226)
-
(1997)
Clinical Pharmacology and Therapeutics
, vol.62
, Issue.4
, pp. 417-425
-
-
Kazierad, D.J.1
Martin, D.E.2
Blum, R.A.3
Tenero, D.M.4
Ilson, B.5
Boike, S.C.6
Etheredge, R.7
Jorkasky, D.K.8
-
7
-
-
0027509397
-
Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans
-
Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br J Clin Pharmacol 1993;35:290-297.
-
(1993)
Br J Clin Pharmacol
, vol.35
, pp. 290-297
-
-
Ohtawa, M.1
Takayama, F.2
Saitoh, K.3
Yoshinaga, T.4
Nakashima, M.5
-
8
-
-
0029068526
-
Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174
-
Christ DD. Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174. J Clin Pharmacol 1995;35:515-520.
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 515-520
-
-
Christ, D.D.1
-
10
-
-
0017188325
-
Absorption, metabolism, and excretion of hydrochlorothiazide
-
Beermann B, Groschinsky-Grind M, Rosen A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther 1976;19:531-537.
-
(1976)
Clin Pharmacol Ther
, vol.19
, pp. 531-537
-
-
Beermann, B.1
Groschinsky-Grind, M.2
Rosen, A.3
-
12
-
-
33644759333
-
Targeting effective blood pressure control with angiotensin receptor blockers
-
Asmar R. Targeting effective blood pressure control with angiotensin receptor blockers. Int J Clin Pract 2006;60:315-320.
-
(2006)
Int J Clin Pract
, vol.60
, pp. 315-320
-
-
Asmar, R.1
-
13
-
-
0030751117
-
Losartan, an orally active angiotensin (AT1) receptor antagonist: A review of its efficacy and safety in essential hypertension
-
McIntyre M, Caffe SE, Michalak RA, Reid JL. Losartan, an orally active angiotensin (AT1) receptor antagonist: A review of its efficacy and safety in essential hypertension. Pharmacol Ther 1997;74:181-194.
-
(1997)
Pharmacol Ther
, vol.74
, pp. 181-194
-
-
McIntyre, M.1
Caffe, S.E.2
Michalak, R.A.3
Reid, J.L.4
-
14
-
-
33745759622
-
Utility of mass spectrometry for pharmaceutical profiling applications
-
Kerns EH, Di L. Utility of mass spectrometry for pharmaceutical profiling applications. Curr Drug Metab 2006;7:457-466.
-
(2006)
Curr Drug Metab
, vol.7
, pp. 457-466
-
-
Kerns, E.H.1
Di, L.2
-
15
-
-
33847758698
-
Tandem mass spectrometry (LC-MS-MS): A predominant role in bioassays for pharmacokinetic studies
-
Marzo A, Bo LD. Tandem mass spectrometry (LC-MS-MS): A predominant role in bioassays for pharmacokinetic studies. Arzneimittelforschung 2007;57:122-128.
-
(2007)
Arzneimittelforschung
, vol.57
, pp. 122-128
-
-
Marzo, A.1
Bo, L.D.2
-
16
-
-
34547294263
-
Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology
-
Maurer HH. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 2007;388:1315-1325.
-
(2007)
Anal Bioanal Chem
, vol.388
, pp. 1315-1325
-
-
Maurer, H.H.1
-
17
-
-
0034752106
-
Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses
-
DOI 10.1016/S0009-8981(01)00667-2, PII S0009898101006672
-
Zhong D, Chen X, Gu J, Li X, Guo J. Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses. Clin Chim Acta 2001; 313:147-150. (Pubitemid 33016705)
-
(2001)
Clinica Chimica Acta
, vol.313
, Issue.1-2
, pp. 147-150
-
-
Zhong, D.1
Chen, X.2
Gu, J.3
Li, X.4
Guo, J.5
-
18
-
-
0031932550
-
HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats
-
Soldner A, Spahn-Langguth H, Mutschler E. HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats. J Pharm Biomed Anal 1998;16:863-873.
-
(1998)
J Pharm Biomed Anal
, vol.16
, pp. 863-873
-
-
Soldner, A.1
Spahn-Langguth, H.2
Mutschler, E.3
-
19
-
-
0034690944
-
Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection
-
Yeung PK, Jamieson A, Smith GJ, Fice D, Pollak PT. Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection. Int J Pharm 2000;204:17-22.
-
(2000)
Int J Pharm
, vol.204
, pp. 17-22
-
-
Yeung, P.K.1
Jamieson, A.2
Smith, G.J.3
Fice, D.4
Pollak, P.T.5
-
20
-
-
1842450834
-
Development of solid-phase extraction method and its application for determination of hydrochlorothiazide in human plasma using HPLC
-
Zendelovska D, Stafilov T, Milosevski P. Development of solid-phase extraction method and its application for determination of hydrochlorothiazide in human plasma using HPLC. Biomed Chromatogr 2004;18:71-76.
-
(2004)
Biomed Chromatogr
, vol.18
, pp. 71-76
-
-
Zendelovska, D.1
Stafilov, T.2
Milosevski, P.3
-
21
-
-
4644280565
-
Combination of losartan and hydrochlorothiazide. in vivo bioequivalence
-
Koytchev R, Ozalp Y, Erenmemisoglu A, van der Meer MJ, Alpan RS. Combination of losartan and hydrochlorothiazide: In vivo bioequivalence. Arzneimittelforschung 2004;54:611-617.
-
(2004)
Arzneimittelforschung
, vol.54
, pp. 611-617
-
-
Koytchev, R.1
Ozalp, Y.2
Erenmemisoglu, A.3
Van Der Meer, M.J.4
Alpan, R.S.5
-
22
-
-
22144456382
-
Comparative pharmacokinetics of two tablet formulations of Losartan: Bioequivalence assessment
-
Tamimi JJ, Salem, II, Mahmood Alam S, Zaman Q, Dham R. Comparative pharmacokinetics of two tablet formulations of Losartan: Bioequivalence assessment. Biopharm Drug Dispos 2005;26:205-210.
-
(2005)
Biopharm Drug Dispos
, vol.26
, pp. 205-210
-
-
Tamimi, J.J.1
Salem, I.I.2
Mahmood Alam, S.3
Zaman, Q.4
Dham, R.5
-
23
-
-
0029917297
-
New sensitive method for the determination of hydrochlorothiazide in human serum by high-performance liquid chromatography with electrochemical detection
-
Richter K, Oertel R, Kirch W. New sensitive method for the determination of hydrochlorothiazide in human serum by high-performance liquid chromatography with electrochemical detection. J Chromatogr A 1996;729:293-296.
-
(1996)
J Chromatogr A
, vol.729
, pp. 293-296
-
-
Richter, K.1
Oertel, R.2
Kirch, W.3
-
24
-
-
33846084399
-
Simultaneous determination of losartan. EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-formatbased solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry
-
Kolocouri F, Dotsikas Y, Apostolou C, Kousoulos C, Loukas YL. Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-formatbased solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry. Anal Bioanal Chem 2007;387:593-601.
-
(2007)
Anal Bioanal Chem
, vol.387
, pp. 593-601
-
-
Kolocouri, F.1
Dotsikas, Y.2
Apostolou, C.3
Kousoulos, C.4
Loukas, Y.L.5
|